<DOC>
	<DOCNO>NCT00547937</DOCNO>
	<brief_summary>Background : Previous study present contradictory data concern obstructive sleep apnea syndrome ( OSAS ) , lipid oxidation nitric oxide ( NO ) bioavailability . This study aim : ( 1 ) compare concentration 8-isoprostane total nitrate nitrite ( NOx ) plasma middle age male OSAS know comorbidity carefully match healthy control age gender ; ( 2 ) test hypothesis nasal continuous positive airway pressure ( CPAP ) therapy , might attenuate oxidative stress nitrate deficiency .</brief_summary>
	<brief_title>Sleep Apnea Oxidative Stress Nitric Oxide</brief_title>
	<detailed_description>We perform single-center , prospective , randomize , double-blind , placebo-controlled cross-over clinical study , patient receive CPAP sham therapy two 12-week period . Baseline measurements healthy control match age gender also obtain . At recruitment , 24-h blood pressure monitoring ( ABPM ) , echocardiogram ( rule cardiac dysfunction ) sleep study obtain participant . After fast overnight , venous blood sample ( anti-coagulated dipotassium EDTA , 8-isoprostane total nitrate nitrite concentration ( NOx ) determination ) urine sample collect 08:00 10:00 hour . Within 30 minute blood collection , plasma obtain centrifugation 3000 rpm 15 min . All plasma sample store −60°C analysis . Patients OSAS underwent full-night CPAP titration study use automated pressure set device ( Auto Set ; ResMed , Sydney , Australia ) . Compliance therapy obtain built-in run-time counter . After 12 week , CPAP device switch alternate mode therapy ABPM , , plasma urine sampling repeat patient</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>apneahypopnea index ( AHI ) ≥10 h1 excessive daytime sleepiness define Epworth scale score ≥11 point treatment OSAS . Inclusion criterion healthy control subject AHI &lt; 5 h1 Epworth sleepiness scale &lt; 10 . unwillingness inability participate study obstructive restrictive lung disease identify pulmonary function test use cardioactive drug cardiac rhythm disturbance , include sinus bradycardia sinus tachycardia know arterial hypertension , 24hour mean blood pressure 135 and/or 85 mm Hg leave ventricular ejection fraction &lt; 50 % , ischemic valve heart disease , hypertrophic , restrictive infiltrative cardiomyopathy , pericardial disease stroke , history , physical examination , ECG , chest radiography , conventional exercise stress testing , echocardiography diabetes mellitus , history 2 random blood glucose level ≥126 mg/dl morbid obesity ( body mass index &gt; 40 Kg/m2 ) daytime hypoxemia ( PaO2 &lt; 70 mm Hg ) hypercapnia ( PaCO2 &gt; 45 mm Hg ) need change medication hospital admission 10 day average nightly CPAP usage le 3.5 hour .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Sleep Apnea</keyword>
	<keyword>Oxidative Stress</keyword>
	<keyword>Nitric oxide</keyword>
	<keyword>Cardiovascular disease</keyword>
</DOC>